Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy
Publication
, Conference
Cotten, CM; Fisher, K; Kurtzberg, J; Simmons, R
Published in: CYTOTHERAPY
2020
Duke Scholars
Published In
CYTOTHERAPY
EISSN
1477-2566
ISSN
1465-3249
Publication Date
2020
Volume
22
Issue
5
Start / End Page
S192 / S192
Related Subject Headings
- Immunology
- 3206 Medical biotechnology
- 3204 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Cotten, C. M., Fisher, K., Kurtzberg, J., & Simmons, R. (2020). Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy. In CYTOTHERAPY (Vol. 22, pp. S192–S192).
Cotten, C. M., K. Fisher, J. Kurtzberg, and R. Simmons. “Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy.” In CYTOTHERAPY, 22:S192–S192, 2020.
Cotten CM, Fisher K, Kurtzberg J, Simmons R. Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy. In: CYTOTHERAPY. 2020. p. S192–S192.
Cotten, C. M., et al. “Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy.” CYTOTHERAPY, vol. 22, no. 5, 2020, pp. S192–S192.
Cotten CM, Fisher K, Kurtzberg J, Simmons R. Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy. CYTOTHERAPY. 2020. p. S192–S192.
Published In
CYTOTHERAPY
EISSN
1477-2566
ISSN
1465-3249
Publication Date
2020
Volume
22
Issue
5
Start / End Page
S192 / S192
Related Subject Headings
- Immunology
- 3206 Medical biotechnology
- 3204 Immunology
- 1103 Clinical Sciences